Moods Disorders Completed Phase 1 Trials for Midomafetamine (DB01454)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01386177Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)Basic Science
NCT00886886Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)Basic Science
NCT00895804Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)Basic Science
NCT00990067Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)Basic Science
NCT01136278Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)Basic Science